| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S00395-003-0433-8 |
| P698 | PubMed publication ID | 14685702 |
| P50 | author | Stefan D. Anker | Q30310195 |
| Ewa A Jankowska | Q40395675 | ||
| Stephan von Haehling | Q50639680 | ||
| P433 | issue | 1 | |
| P921 | main subject | TNF | Q18032037 |
| pathophysiology | Q1135939 | ||
| P304 | page(s) | 18-28 | |
| P577 | publication date | 2003-08-21 | |
| P1433 | published in | Basic Research in Cardiology | Q2453360 |
| P1476 | title | Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications | |
| P478 | volume | 99 |
| Q40395551 | Activation of the NF-kappaB system in peripheral blood leukocytes from patients with chronic heart failure |
| Q36684042 | Anti-tumour necrosis factor-alpha therapy in heart failure: future directions |
| Q45929297 | Arrhythmias and increased neuro-endocrine stress response during physicians' night shifts: a randomized cross-over trial. |
| Q36332873 | Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches |
| Q42845046 | Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra |
| Q54481049 | Cellular endotoxin desensitization in patients with severe chronic heart failure. |
| Q44025446 | Clinical and neurohormonal correlates and prognostic value of serum prolactin levels in patients with chronic heart failure |
| Q43142077 | Cortisol changes interact with the effects of a cognitive behavioural psychological preparation for surgery on 12-month outcomes for surgical heart patients |
| Q36145832 | Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches |
| Q42504822 | Differential expression of matrix metalloproteases in human fibroblasts with different origins |
| Q36087238 | Future prospects of anticytokine therapy in chronic heart failure |
| Q36684755 | Inflammatory biomarkers in heart failure. |
| Q35582235 | Inflammatory mediators in chronic heart failure: an overview |
| Q37330943 | Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy |
| Q36682182 | Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives |
| Q36971596 | Iron status in patients with chronic heart failure |
| Q80814295 | Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats |
| Q44973899 | Omega-3 polyunsaturated fatty acids delay the progression of endotoxic shock-induced myocardial dysfunction |
| Q36162995 | Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies |
| Q48446603 | Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study |
| Q37734294 | Proinflammatory cytokines in heart failure: double-edged swords |
| Q35293910 | Psychobiology of depression/distress in congestive heart failure |
| Q48821619 | Red cell distribution width as a marker of impaired exercise tolerance in patients with chronic heart failure |
| Q37114650 | Review and clinical perspectives for the use of infliximab in ulcerative colitis |
| Q33678981 | Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults |
| Q38492490 | The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study |
| Q38051119 | The immunological axis in heart failure: importance of the leukocyte differential |
| Q33897455 | The influence of heart failure self-care on health outcomes: hypothetical cardioprotective mechanisms |
| Q37939658 | The role of monocytes and inflammation in the pathophysiology of heart failure |
| Q48194839 | The role of serum VCAM-1 and TNF-α as predictors of mortality and morbidity in patients with chronic heart failure. |
| Q21296645 | Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases |
| Q36283524 | Tumor necrosis factor-alpha, biologic agents and cardiovascular risk |
| Q39361054 | Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme |
| Q35954625 | What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. |
| Q46514943 | Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins |
Search more.